2025 Asia-Pacific Blood Stream Infection Testing Market Revenue Opportunities Report
Description
The 2025 Asia-Pacific Blood Stream Infection Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Asia-Pacific bloodstream infection testing market are bioMérieux SA, Becton Dickinson (BD), Cepheid, and Seegene Inc. bioMérieux offers diagnostic solutions such as BACT/ALERT and VITEK MS systems, with a strong presence in China, India, and Japan where rapid molecular diagnostics are in demand. BD provides platforms like BD BACTEC and BD Phoenix, focusing on automated blood culture and susceptibility testing, supported by acquisitions to expand its technology portfolio. Cepheid is known for its Xpert assays targeting MRSA, vancomycin resistance, and carbapenemase-producing bacteria, enhancing rapid pathogen detection. Seegene contributes multiplex PCR panels like the Allplex Sepsis Panel for comprehensive pathogen identification.
These companies are capitalizing on the Asia-Pacific region's fastest growth trajectory due to rising healthcare spending, increasing hospital-acquired infections, and government initiatives for infection surveillance. For instance, China's National Healthcare-Associated Infection Surveillance System (NHAISS) accelerates adoption of rapid diagnostics. The market growth is also propelled by the rising antimicrobial resistance burden and advancements in automated testing platforms. Together, these firms lead technological innovation, expand testing capacities, and collaborate with local healthcare infrastructures to meet increasing regional demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Asia-Pacific bloodstream infection testing market are bioMérieux SA, Becton Dickinson (BD), Cepheid, and Seegene Inc. bioMérieux offers diagnostic solutions such as BACT/ALERT and VITEK MS systems, with a strong presence in China, India, and Japan where rapid molecular diagnostics are in demand. BD provides platforms like BD BACTEC and BD Phoenix, focusing on automated blood culture and susceptibility testing, supported by acquisitions to expand its technology portfolio. Cepheid is known for its Xpert assays targeting MRSA, vancomycin resistance, and carbapenemase-producing bacteria, enhancing rapid pathogen detection. Seegene contributes multiplex PCR panels like the Allplex Sepsis Panel for comprehensive pathogen identification.
These companies are capitalizing on the Asia-Pacific region's fastest growth trajectory due to rising healthcare spending, increasing hospital-acquired infections, and government initiatives for infection surveillance. For instance, China's National Healthcare-Associated Infection Surveillance System (NHAISS) accelerates adoption of rapid diagnostics. The market growth is also propelled by the rising antimicrobial resistance burden and advancements in automated testing platforms. Together, these firms lead technological innovation, expand testing capacities, and collaborate with local healthcare infrastructures to meet increasing regional demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
